Conlin O'neil

Title: Conlin O'neil: Innovator in Synthetic Nanocarriers

Introduction

Conlin O'neil is a notable inventor based in the United States, recognized for his contributions to the field of synthetic nanocarriers. His innovative work focuses on the development of methods and compositions that enhance the efficacy of nanocarrier systems.

Latest Patents

Although Conlin O'neil currently holds no patents, he has been involved in significant research that has led to the disclosure of two important patent applications. The first application, titled "Methods And Compositions Related To The Use Of Low HLB Surfactants In The Production Of Synthetic Nanocarriers Comprising A Rapalog," outlines compositions and methods that utilize a hydrophobic carrier material, a rapalog, and a non-ionic surfactant with a hydrophilic-lipophilic balance (HLB) value of 10 or less. The second application, "Methods And Compositions Related To Synthetic Nanocarriers With Rapamycin In A Stable, Super-Saturated State," describes synthetic nanocarriers that incorporate hydrophobic polyester carrier material and rapamycin in a stable, super-saturated amount, with some embodiments being initially sterile filterable.

Career Highlights

Conlin O'neil is currently employed at Selecta Biosciences, Inc., where he continues to advance his research in the field of nanotechnology. His work is pivotal in developing innovative solutions that could potentially transform therapeutic delivery systems.

Collaborations

Throughout his career, Conlin has collaborated with esteemed colleagues, including Aaron P Griset and David H Altreuter. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Conlin O'neil's contributions to the field of synthetic nanocarriers highlight his commitment to advancing technology in therapeutic applications. His ongoing research and collaborations position him as a key figure in the development of innovative solutions in nanotechnology.